Awarded contract

NHS Framework Agreement for the supply of Adult Influenza Vaccines – Secondary Care

  • The NHS Commissioning Board (operating under the name of NHS England)

F03: Contract award notice

Notice reference: 2021/S 000-022304

Published 8 September 2021, 3:50pm



Section one: Contracting authority

one.1) Name and addresses

The NHS Commissioning Board (operating under the name of NHS England)

2nd Floor, Rutland House

Runcorn

WA7 2ES

Contact

Philip Grieve

Email

philip.grieve@nhs.net

Country

United Kingdom

NUTS code

UK - United Kingdom

Internet address(es)

Main address

https://www.england.nhs.uk/

Buyer's address

https://www.england.nhs.uk/

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.4) Type of the contracting authority

Ministry or any other national or federal authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

NHS Framework Agreement for the supply of Adult Influenza Vaccines – Secondary Care

Reference number

CM/PHS/20/5623

two.1.2) Main CPV code

  • 33651660 - Influenza vaccines

two.1.3) Type of contract

Supplies

two.1.4) Short description

NHS Framework Agreement for the supply of Adult Influenza Vaccines – Secondary Care. Period of framework agreement: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months . Please refer to the invitation to offer documents for a list of the purchasing points.

two.1.6) Information about lots

This contract is divided into lots: Yes

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £68,184,420

two.2) Description

two.2.1) Title

Lot 1 - aQIV

Lot No

1

two.2.2) Additional CPV code(s)

  • 33651660 - Influenza vaccines

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom
Main site or place of performance

Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)

two.2.4) Description of the procurement

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

two.2.5) Award criteria

Quality criterion - Name: Security of Supply / Weighting: 10%

Quality criterion - Name: Ease of Use / Weighting: 3%

Price - Weighting: 87%

two.2.11) Information about options

Options: Yes

Description of options

option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2) Description

two.2.1) Title

Lot 2 - QIV-HD

Lot No

2

two.2.2) Additional CPV code(s)

  • 33651660 - Influenza vaccines

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom
Main site or place of performance

Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)

two.2.4) Description of the procurement

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

two.2.5) Award criteria

Quality criterion - Name: Security of Supply / Weighting: 10%

Quality criterion - Name: Ease of Use / Weighting: 3%

Price - Weighting: 87%

two.2.11) Information about options

Options: Yes

Description of options

option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2) Description

two.2.1) Title

Lot 3 - QIVc

Lot No

3

two.2.2) Additional CPV code(s)

  • 33651660 - Influenza vaccines

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom
Main site or place of performance

Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)

two.2.4) Description of the procurement

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

two.2.5) Award criteria

Quality criterion - Name: Security of Supply / Weighting: 10%

Quality criterion - Name: Ease of Use / Weighting: 3%

Price - Weighting: 87%

two.2.11) Information about options

Options: Yes

Description of options

option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2) Description

two.2.1) Title

Lot 4 - QIVr

Lot No

4

two.2.2) Additional CPV code(s)

  • 33651660 - Influenza vaccines

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom
Main site or place of performance

Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)

two.2.4) Description of the procurement

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

two.2.5) Award criteria

Quality criterion - Name: Security of Supply / Weighting: 10%

Quality criterion - Name: Ease of Use / Weighting: 3%

Price - Weighting: 87%

two.2.11) Information about options

Options: Yes

Description of options

option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2) Description

two.2.1) Title

Lot 5 - QIVe

Lot No

5

two.2.2) Additional CPV code(s)

  • 33651660 - Influenza vaccines

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom
Main site or place of performance

Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)

two.2.4) Description of the procurement

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

two.2.5) Award criteria

Quality criterion - Name: Security of Supply / Weighting: 10%

Quality criterion - Name: Ease of Use / Weighting: 3%

Price - Weighting: 87%

two.2.11) Information about options

Options: Yes

Description of options

option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.1) Previous publication concerning this procedure

Notice number: 2021/S 000-009004


Section five. Award of contract

Contract No

CM/PHS/20/5623

Lot No

1

Title

aQIV

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

18 August 2021

five.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from other EU Member States: 2

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Seqirus UK Limited

Point, 29 Market Street

Maidenhead

SL6 8AA

Country

United Kingdom

NUTS code
  • UK - United Kingdom
The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Lowest offer: £1 / Highest offer: £1 taken into consideration


Section five. Award of contract

Contract No

CM/PHS/20/5623

Lot No

3

Title

QIVc

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

18 August 2021

five.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from other EU Member States: 2

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Seqirus UK Limited

Point, 29 Market Street

Maidenhead

SL6 8AA

Country

United Kingdom

NUTS code
  • UK - United Kingdom
The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Lowest offer: £1 / Highest offer: £1 taken into consideration


Section five. Award of contract

Contract No

CM/PHS/20/5623

Lot No

4

Title

QIVr

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

18 August 2021

five.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from other EU Member States: 2

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Aventis Pharma ltd t/a Sanofi

410 Thames Valley, Park Drive, Reading

Reading

RG6 1PT

Country

United Kingdom

NUTS code
  • UK - United Kingdom
The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Lowest offer: £1 / Highest offer: £1 taken into consideration


Section five. Award of contract

Contract No

CM/PHS/20/5623

Lot No

5

Title

QIVe

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

18 August 2021

five.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from other EU Member States: 2

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Aventis Pharma ltd t/a Sanofi

410 Thames Valley, Park Drive, Reading

Reading

RG6 1PT

Country

United Kingdom

NUTS code
  • UK - United Kingdom
The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Lowest offer: £1 / Highest offer: £1 taken into consideration


Section five. Award of contract

A contract/lot is awarded: No

five.1) Information on non-award

The contract/lot is not awarded

No tenders or requests to participate were received or all were rejected


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

The High Court

Strand

London

WC2A 2LL

Email

generaloffice@administrativecourtoffice.justice.gov.uk

Country

United Kingdom

Internet address

https://www.gov.uk/courts-tribunals